Deutsche Bank maintains ‘buy’ on Creo Medical after strong FY25 growth Deutsche Bank has reiterated its ‘buy’ rating on Creo Medical Group PLC (AIM:CREO, FRA:1RC, OTC:CMEOF), following a trading update that…
Creo Medical tipped for major upside as commercial story continues to gain traction Deutsche Bank has repeated a Buy rating for Creo Medical Group PLC (AIM:CREO, OTC:CMEOF) following a capital markets day showcase that...…
Creo Medical tipped for major upside as commercial story continues to gain traction Deutsche Bank has repeated a Buy rating for Creo Medical Group PLC (AIM:CREO, OTC:CMEOF) following a capital markets day showcase that...…
Creo Medical making progress Creo Medical Group PLC (AIM:CREO, OTC:CMEOF) has told investors it is “remaining on track”, with Cavendish highlighting a stronger balance…
Creo Medical confident of hitting full-year growth targets after strong first half Creo Medical Group PLC (AIM:CREO, OTC:CMEOF) said it remains on track to deliver 40–60% revenue growth this year after reporting…
Creo Medical eyes 50% growth with new tech Creo Medical Group PLC CEO Craig Gulliford talked with Proactive about the company’s strong performance in 2024 and strategic plans…